Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s):  MDXXF

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.


CSE:MDMA - Post by User

Comment by inviolablspiriton Jan 15, 2025 1:33pm
32 Views
Post# 36405386

RE:Doubtful

RE:Doubtful I agree, institutions trade extremely large volumes of shares in the 10's of millions.   However, I did trade a few shares based on the view that the stock was trading in a predictable fashion and it work perfectly.  People on CEO seem to have collectively agreed that news typically comes out on the Monday or Tuesday so I watched the trading pattern of this stock based on an imminent news release.  I know I was taking a risk with those shares, which is why I traded only a few, but I wanted to prove to myself that this stock had been moving in a very predictable pattern.  It was certainly stressful to test this theory because I don't want to be chasing my shares back if I'm wrong.  Perhaps it was a coincidence that the stock traded the same way as the previous weeks, but it did trade as predicted.  I was not willing to try it again this week; once was enough. I am willing to concede that I may be jumping to conclusions as you say, but it worked so predictably well that it's hard not think that it was not manipulated.  Very strange that it traded in such a mirror-like fashion.  

Hopefully this week that pattern it broken to the upside and that the stock remains there.    Q1 financials are just around the corner (i.e. January 30).  We may see those before any other news release.  
<< Previous
Bullboard Posts
Next >>